EGFR and non-small cell lung carcinoma: This population-based study therefore aimed to estimate the population-based incidence rates of EGFR mutation-positive and EGFR mutation-negative non-squamous NSCLC in different population groups defined by age, sex, ethnic group—especially the indigenous Māori people and Pacific peoples, and smoking status, based on northern New Zealand data.